These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9685243

  • 1. A new approach to the design of novel inhibitors of Na+,K+-ATPase: 17alpha-substituted seco-D 5beta-androstane as cassaine analogues.
    De Munari S, Barassi P, Cerri A, Fedrizzi G, Gobbini M, Mabilia M, Melloni P.
    J Med Chem; 1998 Jul 30; 41(16):3033-40. PubMed ID: 9685243
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 17beta-O-Aminoalkyloximes of 5beta-androstane-3beta,14beta-diol with digitalis-like activity: synthesis, cardiotonic activity, structure-activity relationships, and molecular modeling of the Na(+),K(+)-ATPase receptor.
    Cerri A, Almirante N, Barassi P, Benicchio A, Fedrizzi G, Ferrari P, Micheletti R, Quadri L, Ragg E, Rossi R, Santagostino M, Schiavone A, Serra F, Zappavigna MP, Melloni P.
    J Med Chem; 2000 Jun 15; 43(12):2332-49. PubMed ID: 10882359
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elucidation of the Na+, K+-ATPase digitalis binding site.
    Keenan SM, DeLisle RK, Welsh WJ, Paula S, Ball WJ.
    J Mol Graph Model; 2005 Jun 15; 23(6):465-75. PubMed ID: 15886034
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular modelling studies on the digitalis binding site of the Na+/K(+)-ATPase.
    Höltje HD, Anzali S.
    Pharmazie; 1992 Sep 15; 47(9):691-7. PubMed ID: 1335579
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A sensitive [Na,K]ATPase assay specific for inhibitors acting through the digitalis-binding site.
    Tao QF, Soszynski PA, Hollenberg NK, Graves SW.
    J Cardiovasc Pharmacol; 1995 Jun 15; 25(6):859-63. PubMed ID: 7564329
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: A new paradigm for development of anti- breast cancer drugs?
    Chen JQ, Contreras RG, Wang R, Fernandez SV, Shoshani L, Russo IH, Cereijido M, Russo J.
    Breast Cancer Res Treat; 2006 Mar 15; 96(1):1-15. PubMed ID: 16322895
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
    Paula S, Tabet MR, Ball WJ.
    Biochemistry; 2005 Jan 18; 44(2):498-510. PubMed ID: 15641774
    [Abstract] [Full Text] [Related]

  • 18. A QSAR study on a series of simplified digitalis-like compounds acting on Na+,K(+)-ATPase.
    Seelam J, Satuluri VS, Gupta SP, Anwer Z.
    Indian J Biochem Biophys; 2011 Jun 18; 48(3):158-63. PubMed ID: 21793306
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.